These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 36508352)

  • 1. CRISPR-Based Diagnostics: Challenges and Potential Solutions toward Point-of-Care Applications.
    Ghouneimy A; Mahas A; Marsic T; Aman R; Mahfouz M
    ACS Synth Biol; 2023 Jan; 12(1):1-16. PubMed ID: 36508352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CRISPR-Cas systems for diagnosing infectious diseases.
    Kostyusheva A; Brezgin S; Babin Y; Vasilyeva I; Glebe D; Kostyushev D; Chulanov V
    Methods; 2022 Jul; 203():431-446. PubMed ID: 33839288
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CRISPR-based systems for sensitive and rapid on-site COVID-19 diagnostics.
    Soh JH; Balleza E; Abdul Rahim MN; Chan HM; Mohd Ali S; Chuah JKC; Edris S; Atef A; Bahieldin A; Ying JY; Sabir JSM
    Trends Biotechnol; 2022 Nov; 40(11):1346-1360. PubMed ID: 35871983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lab-on-a-Disc for Point-of-Care Infection Diagnostics.
    Sunkara V; Kumar S; Sabaté Del Río J; Kim I; Cho YK
    Acc Chem Res; 2021 Oct; 54(19):3643-3655. PubMed ID: 34516092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CRISPR-Cas enzymes: The toolkit revolutionizing diagnostics.
    Verosloff MS; Shapiro SJ; Hawkins EM; Alpay E; Verma D; Stanfield EG; Kreindler L; Jain S; McKay B; Hubbell SA; Hendriks CG; Blizard BA; Broughton JP; Chen JS
    Biotechnol J; 2022 Jul; 17(7):e2100304. PubMed ID: 34505742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanistic insights of CRISPR/Cas nucleases for programmable targeting and early-stage diagnosis: A review.
    Habimana JD; Huang R; Muhoza B; Kalisa YN; Han X; Deng W; Li Z
    Biosens Bioelectron; 2022 May; 203():114033. PubMed ID: 35131696
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Integrating CRISPR/Cas within isothermal amplification for point-of-Care Assay of nucleic acid.
    Zhang L; Jiang H; Zhu Z; Liu J; Li B
    Talanta; 2022 Jun; 243():123388. PubMed ID: 35303554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [CRISPR-based molecular diagnostics: a review].
    Sun W; Huang X; Wang X
    Sheng Wu Gong Cheng Xue Bao; 2023 Jan; 39(1):60-73. PubMed ID: 36738201
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CRISPR-Cas Biochemistry and CRISPR-Based Molecular Diagnostics.
    Weng Z; You Z; Yang J; Mohammad N; Lin M; Wei Q; Gao X; Zhang Y
    Angew Chem Int Ed Engl; 2023 Apr; 62(17):e202214987. PubMed ID: 36710268
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Novel Miniature CRISPR-Cas13 System for SARS-CoV-2 Diagnostics.
    Mahas A; Wang Q; Marsic T; Mahfouz MM
    ACS Synth Biol; 2021 Oct; 10(10):2541-2551. PubMed ID: 34546709
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CRISPR-Based COVID-19 Testing: Toward Next-Generation Point-of-Care Diagnostics.
    Ganbaatar U; Liu C
    Front Cell Infect Microbiol; 2021; 11():663949. PubMed ID: 33996635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CRISPR-Cas based virus detection: Recent advances and perspectives.
    Yin L; Man S; Ye S; Liu G; Ma L
    Biosens Bioelectron; 2021 Dec; 193():113541. PubMed ID: 34418634
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Point-of-Care Pathogen Detection with CRISPR-based Programmable Nucleic Acid Binding Proteins.
    Dhar BC; Steimberg N; Mazzoleni G
    ChemMedChem; 2021 May; 16(10):1566-1575. PubMed ID: 33258314
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Point-of-care CRISPR-Cas-assisted SARS-CoV-2 detection in an automated and portable droplet magnetofluidic device.
    Chen FE; Lee PW; Trick AY; Park JS; Chen L; Shah K; Mostafa H; Carroll KC; Hsieh K; Wang TH
    Biosens Bioelectron; 2021 Oct; 190():113390. PubMed ID: 34171821
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CRISPR-based tools: Alternative methods for the diagnosis of COVID-19.
    Palaz F; Kalkan AK; Tozluyurt A; Ozsoz M
    Clin Biochem; 2021 Mar; 89():1-13. PubMed ID: 33428900
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nucleic Acid Detection Using CRISPR/Cas Biosensing Technologies.
    Aman R; Mahas A; Mahfouz M
    ACS Synth Biol; 2020 Jun; 9(6):1226-1233. PubMed ID: 32159950
    [TBL] [Abstract][Full Text] [Related]  

  • 17. CRISPR-based point-of-care plant disease diagnostics.
    Islam T; Kasfy SH
    Trends Biotechnol; 2023 Feb; 41(2):144-146. PubMed ID: 36272820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Point-of-care CRISPR/Cas nucleic acid detection: Recent advances, challenges and opportunities.
    van Dongen JE; Berendsen JTW; Steenbergen RDM; Wolthuis RMF; Eijkel JCT; Segerink LI
    Biosens Bioelectron; 2020 Oct; 166():112445. PubMed ID: 32758911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CRISPR-based biosensing systems: a way to rapidly diagnose COVID-19.
    Vatankhah M; Azizi A; Sanajouyan Langeroudi A; Ataei Azimi S; Khorsand I; Kerachian MA; Motaei J
    Crit Rev Clin Lab Sci; 2021 Jun; 58(4):225-241. PubMed ID: 33245685
    [TBL] [Abstract][Full Text] [Related]  

  • 20. iSCAN: An RT-LAMP-coupled CRISPR-Cas12 module for rapid, sensitive detection of SARS-CoV-2.
    Ali Z; Aman R; Mahas A; Rao GS; Tehseen M; Marsic T; Salunke R; Subudhi AK; Hala SM; Hamdan SM; Pain A; Alofi FS; Alsomali A; Hashem AM; Khogeer A; Almontashiri NAM; Abedalthagafi M; Hassan N; Mahfouz MM
    Virus Res; 2020 Oct; 288():198129. PubMed ID: 32822689
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.